Year 2023 is expected to be tough year for most markets, investors and consumers. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. With slower growth and high inflation, developed markets seem primed to enter into a recession.
The industry is witnessing growth due to factors, such increasing burden of chronic diseases and the growing demand for early diagnostic tests. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. The global clinical laboratory service market size was estimated at USD 217.53 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.2 from 2023 to 2030. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Higher retail inflation will impact consumer confidence and spending. Food and fuel inflation will remain a persistent economic problem. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Looking Ahead to 2023The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. Access to digital archives and Research Platform.Online interactive peer-to-peer collaborative bespoke updates Department of Pathology, Clinical Laboratories Located on the second floor of the hospital.Market presence across multiple geographies - Strong/Active/Niche/Trivial.Global competitiveness and key competitor percentage market shares.Special coverage on Russia-Ukraine war global inflation easing of zero-Covid policy in China and its `bumpy` reopening supply chain disruptions, global trade tensions and risk of recession.Bioscientia Institut für Medizinische Diagnostik GmbH.Laboratory Corporation of America Holdings.Select Competitors (Total 125 Featured). Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$21 Billion by the year 2030. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 4.9% respectively over the 2022-2030 period. China, the world's second largest economy, is forecast to reach a projected market size of US$15.8 Billion by the year 2030 trailing a CAGR of 7.4% over the analysis period 2022 to 2030. is estimated at US$118.7 Billion in the year 2022. Market is Estimated at $118.7 Billion, While China is Forecast to Grow at 7.4% CAGRThe Clinical Laboratory Services market in the U.S.
0 kommentar(er)
